Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 23,971 | 23,873 | 34,995 | 22,297 | 22,543 |
| Cost of Goods | 4,159 | 5,105 | 4,170 | 3,743 | 3,902 |
| Gross Profit | 19,812 | 18,768 | 30,825 | 18,554 | 18,641 |
| Operating Expenses | 20,460 | 21,257 | 21,512 | 19,204 | 21,536 |
| Operating Income | -489 | -2,384 | 9,483 | 93 | -1,993 |
| Interest Expense | 132 | 59 | 59 | 60 | 34 |
| Other Income | 59 | -68 | 101 | -139 | -51 |
| Pre-tax Income | -562 | -2,511 | 9,525 | -106 | -2,078 |
| Income Tax | -273 | 776 | 1,438 | 168 | 868 |
| Net Income Continuous | -289 | -3,287 | 8,087 | -274 | -2,946 |
| Net Income | $-289 | $-3,287 | $8,087 | $-274 | $-2,946 |
| EPS Basic Total Ops | -0.02 | -0.24 | 0.59 | -0.02 | -0.22 |
| EPS Basic Continuous Ops | -0.02 | -0.24 | 0.59 | -0.02 | -0.22 |
| EPS Diluted Total Ops | -0.02 | -0.24 | 0.58 | -0.02 | -0.22 |
| EPS Diluted Continuous Ops | -0.02 | -0.24 | 0.58 | -0.02 | -0.21 |
| EBITDA(a) | $1,964 | $-540 | $11,389 | $1,953 | $-120 |